期刊文献+

预防性规范化护理干预在注射用多西他赛化疗中的应用 被引量:7

Application of Standardized Preventive Nursing Intervention in Chemotherapy with Docetaxel for Injection
原文传递
导出
摘要 目的:探讨注射用多西他赛(D)+顺铂(P)方案治疗晚期卵巢癌的不良反应及减少不良反应的规范化护理措施。方法:用DP方案治疗晚期卵巢癌患者63例。用法:D75mg.m-2,P80mg.m-2,均为第1天静脉滴注,3wk为1个周期,至少应用2个周期。记录药品不良反应,并找出相应的预防性规范化护理措施。结果:干预前不良反应发生率为:脱发82.1%,骨髓抑制和胃肠道反应均71.4%,神经毒性及过敏反应21.4%、14.3%,后果最严重的是过敏反应。预防性规范化护理干预后,过敏反应发生率为0.0%,胃肠道反应为42.9%,干预前、后比较均有极显著性差异(P<0.01)。结论:预防性规范化护理干预措施可有效降低注射用多西他赛治疗卵巢癌的不良反应,提高疗效。 OBJECTIVE: To study the adverse reactions of combination chemotherapy with docetaxel(D) and cisplatin(P) in the treatment of advanced ovarian cancer, and discuss standardized nursing intervention measures for reducing the adverse reactions.METHODS:63 patients suffering from advanced ovarian cancer were treated with the DP therapy .Docetaxel 75mg · m ^-2 was given through iv drop infusion on the first day, and Cisplatin 80mg · m^-2 was given through iv drop infusion on the first, second and third day, for at last two three - week schedules.Clinical adverse reactions were observed and recorded, and corresponding standardized preventive nursing intervention measures were worked out and taken.RESULTS: The pre- intervention occurrence rates for adverse reactions are as follows: alopecia(82.1% ), bone marrow depression and gastrointestinal tract reaction( 71.4 % ), neurotoxicity ( 21. 4 % ), allergic response( 14.3 % ), with allergic response causing the most severe consequence.The post- intervention occurrence rates for adverse reactions are as follows: allergic response(0.0% ), gastrointestinal tract reaction( 42.9% ) .When the two results are compared, there is a significant statistical implication( P 〈 0.01).CONCLUSION: Standardized preventive nursing intervention can effectively reduce the adverse reactions induced by combination chemotherapy with doeetaxel and cisplatin,and can enhance curative effects.
出处 《中国药房》 CAS CSCD 北大核心 2007年第8期612-613,共2页 China Pharmacy
关键词 多西他赛 顺铂 不良反应 护理干预 Docetaxel Cisplatin Adverse reactions Nursing intervention
  • 相关文献

参考文献5

二级参考文献16

  • 1王彬,惠锦林,吴蓓.经腹腔和静脉双途径应用紫杉醇化疗治疗晚期卵巢癌[J].临床肿瘤学杂志,2004,9(3):260-261. 被引量:2
  • 2潘春霞,徐晓辉,张捷,付静.艾素治疗晚期非小细胞肺癌及乳腺癌43例近期疗效观察[J].中国误诊学杂志,2004,4(11):1859-1860. 被引量:3
  • 3张中冕,刘萍,田薇薇,王健,韩娜,梁冰.盖诺联合顺铂序贯沙利度胺治疗晚期非小细胞肺癌临床观察[J].山东医药,2005,45(19):57-57. 被引量:5
  • 4张蓉,许培箴,喻康,王秋伟,董一善.上皮性卵巢癌Ⅲ期的综合治疗及预后分析[J].中国癌症杂志,2005,15(6):572-574. 被引量:1
  • 5周际昌主编.实用内科肿瘤学.第1版[M].北京:人民卫生出版社,1996.437-438.
  • 6Kosmidis P, Mylonakis N, Nicolaides C, et al .Paelitaxel plus carboplatin versus gemcitabine plus paelitaxel in advanced non- small- cell lung cancer: a phase III randomized trial [J ] .J Clin Oncol, 2002,20(17) : 3 578.
  • 7Evams WK,Stewart DJ ,Tomiak,E,et al .Carboplatin and paclitaxel by 1 - hour infusion for advanced non - small cell lung cancer[J ] .Pro Am Soc Clin Oncol, 1995,14:374.
  • 8Rosell R,Gatzemeier U,Betticher DC, et al .Phase III randomised trial comparing paclitaxel/ carboplatin with paclitaxel/cisplatin in patients with advanced non - small- cell lung cancer:a cooperative multinational trial[J].Ann Oncol,2002,13(10) : 1 539.
  • 9Langer C J, Leighton JC, Comis RL, et al .Paclitaxel by 24- hour or 1 - hour infusion in combination with carboplatin in advanced non- small cell lung cancer: the Fox Chase Cancer Center experience[J] . Semin Oncol,1995,22:18.
  • 10马胜林.肿瘤热化疗的研究进展[D].中国临床肿瘤学论文辑教育专辑,2004:364-365.

共引文献17

同被引文献13

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部